Live Chat

Fetus Receives One-Third of Maternal Exposure to Lexapro

The makers of Lexapro (escitalopram) are not only required to make a reasonably safe product, but also to warn consumers about the extent to which ingestion of this dangerous drug might harm the patient’s unborn child.

 

Whatever the written warning, the reality is that of the more than 80,000 pregnant women who annually take Lexapro and other selective serotonin reuptake inhibitors (SSRIs), many have no idea that their fetus is exposed to as much as 1/3 of their SSRI dosage. Many women also don’t realize until it’s too late that SSRI medications have been linked to a series of neonatal birth defects, including PPHN, omphalocele, anal atresia, limb reduction, and septal defects.

 

Moreover, many patients don’t understand that the risks associated with SSRI exposure are particularly pronounced during the first trimester and continue through the period during which the child breastfeeds.

 

Fortunately for you and your family, the attorneys at the Dallas law firm of Fears Nachawati can give you the information you need about the legal effects of your SSRI prescription. If your newborn has been injured through his or her fetal exposure to your SSRI medication, we can advise you of your legal rights. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!

Categories
Drug Litigation

Fetus Receives One-Third of Maternal Exposure to Lexapro